LCN2 and Alzheimer disease: Immunofluorescence reveled that LCN2-positive glial fibrillary acidic protein (GFAP)-labeled astrocytes were increased simultaneously in the Aβ-positive amyloid plaques in the human frontal cortex of AD patients (Figure 1C).